Related Experiment Video

Updated: May 30, 2026

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies
07:59

Demystifying In Vivo Bioluminescence Imaging of a Chagas Disease Mouse Model for Drug Efficacy Studies

Published on: May 31, 2024

Cell-based therapy in Chagas disease

Antonio C Campos de Carvalho1, Adriana B Carvalho, Regina C S Goldenberg

  • 1Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro and National Cardiology Institute, Rio de Janeiro, RJ, Brazil.

Advances in Parasitology
|August 9, 2011
PubMed

Insights

Cell-based therapies offer a promising new avenue for treating Chagasic cardiomyopathy, a severe heart condition. These innovative treatments may help regenerate damaged heart tissue and improve the prognosis for affected patients.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Regenerative Medicine

Background:

  • Chagas disease, a neglected tropical illness, causes cardiomyopathy with a poor prognosis.
  • The underlying mechanisms of chagasic cardiomyopathy are not fully understood.
  • Current treatments for heart failure in Chagas disease are limited to standard therapies.

Purpose of the Study:

  • To review the current knowledge on cell-based therapies for Chagas disease.
  • To explore the potential of cell-based treatments in addressing chagasic cardiomyopathy.
  • To highlight the regenerative and immunomodulatory effects of cell therapies.

Main Methods:

  • Literature review of preclinical and clinical studies on cell-based therapies for Chagas disease.
  • Analysis of studies investigating the mechanisms of cell therapy in the context of Chagas disease.
  • Synthesis of current evidence on the efficacy and safety of cell-based approaches.

Main Results:

  • Cell-based therapies show potential in replacing damaged cardiomyocytes and blood vessels.
  • These therapies may modulate the inflammatory microenvironment perpetuating the disease.
  • Emerging research suggests possible benefits for heart function and disease progression.

Conclusions:

  • Cell-based therapies represent a novel and promising treatment strategy for Chagasic cardiomyopathy.
  • Further research is needed to optimize cell types, delivery methods, and long-term outcomes.
  • These therapies offer hope for improving the management of heart failure in Chagas disease.

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...